Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/29/2025

Syphilis Diagnosis and Management

Introduction to Syphilis Testing

  • The Centers for Disease Control and Prevention (CDC) recommends a combination of RPR (nontreponemal test) and T. pallidum antibody (treponemal test) for accurate diagnosis of syphilis, as using only one type of test is insufficient 1, 2, 3

Test Characteristics

  • RPR tests correlate with disease activity and treatment response, with titers usually decreasing after successful treatment, and 15-25% of patients remaining "serofast" with persistent low titers despite adequate treatment 1, 2, 4
  • Treponemal tests usually remain reactive for life regardless of treatment, with 15-25% of patients treated during primary stage may revert to nonreactive after 2-3 years, and poor correlation with disease activity 1, 2

Sensitivity and Specificity

  • RPR sensitivity is 78-86% for primary syphilis, 100% for secondary syphilis, 95-100% for early latent syphilis, and 61-75% for late latent syphilis 5
  • Treponemal tests have higher sensitivity, approaching 100% in most stages 1, 2

Diagnostic Algorithm

  • The traditional approach to syphilis diagnosis involves screening with a nontreponemal test (RPR) and confirming with a treponemal test, while the reverse algorithm involves screening with a treponemal test and confirming with a nontreponemal test 6

Treatment

  • The CDC recommends benzathine penicillin G 2.4 million units IM as a single dose as the first-line treatment for early syphilis, and doxycycline 100 mg orally twice daily for 14 days as an alternative treatment for patients with penicillin allergy 1, 3
  • For late syphilis, the CDC recommends benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (total 7.2 million units) as the first-line treatment 1, 3
  • For neurosyphilis, the CDC recommends aqueous crystalline penicillin G 18-24 million units IV daily (3-4 million units every 4 hours) for 10-14 days as the first-line treatment 1, 3
  • Penicillin is the only proven effective therapy for syphilis during pregnancy, and pregnant women with penicillin allergy should be desensitized and treated with penicillin 3
  • HIV-infected patients should receive the same treatment regimens as HIV-negative patients, with some experts recommending three weekly doses of benzathine penicillin G for early syphilis in HIV-infected patients 3, 4

Treatment Monitoring

  • RPR titers should be used to monitor treatment response, with a fourfold change in titer (equivalent to two dilutions) considered clinically significant, and treponemal tests should not be used to assess treatment response 1, 2, 4
  • Quantitative nontreponemal tests (RPR) should be performed at 3, 6, 9, 12, and 24 months after treatment to monitor treatment response 4
  • Treatment success is defined as a fourfold decrease in titer (equivalent to a change of two dilutions), and clinical and serological evaluation should be performed at 6 and 12 months after therapy 4

Special Considerations

  • HIV-infected patients may have abnormal serologic results, and the prozone phenomenon can occur in approximately 0.5% of reactive samples 1, 2
  • A positive RPR (nontreponemal test) combined with a positive treponemal antibody test confirms the diagnosis of syphilis, ruling out false-positive nontreponemal results that can occur with various medical conditions 3
  • Common pitfalls in follow-up include switching between different nontreponemal tests, using treponemal tests to monitor treatment response, and failing to distinguish between treatment failure and reinfection 4
  • Inadequate follow-up duration, especially in latent syphilis cases, can lead to misinterpretation of treatment response 4